We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+10.38%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$52.5B
AUM Growth
+$3.43B
Cap. Flow
-$722M
Cap. Flow %
-1.38%
Top 10 Hldgs %
14.5%
Holding
3,132
New
75
Increased
2,208
Reduced
412
Closed
54

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$69.9M
2
TMO icon
Thermo Fisher Scientific
TMO
+$67.9M
3
WFC icon
Wells Fargo
WFC
+$64.1M
4
JPM icon
JPMorgan Chase
JPM
+$63.1M
5
PFE icon
Pfizer
PFE
+$62.5M

Sector Composition

Rank Sector Weight
1 Financials 14.51%
2 Healthcare 13.47%
3 Technology 13.05%
4 Industrials 11.46%
5 Energy 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HZNP
2551
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$561K ﹤0.01%
73,500
PSTB
2552
DELISTED
Park Sterling Corp.
PSTB
$558K ﹤0.01%
78,149
-10,419
-12% -$68.4K
CBK
2553
DELISTED
Christopher & Banks Corporation
CBK
$557K ﹤0.01%
65,200
XLRN
2554
DELISTED
Acceleron Pharma
XLRN
$554K ﹤0.01%
+13,975
New +$337K
FBNK
2555
DELISTED
First Connecticut Bancorp, Inc
FBNK
$551K ﹤0.01%
34,175
+1,008
+3% +$15.7K
AGX icon
2556
Argan
AGX
$8.15B
$549K ﹤0.01%
19,900
FRPH icon
2557
FRP Holdings
FRPH
$415M
$548K ﹤0.01%
26,378
+864
+3% +$16.4K
SFXE
2558
DELISTED
SFX ENTERTAINMENT, INC COM
SFXE
$548K ﹤0.01%
+45,618
New +$458K
DCO icon
2559
Ducommun
DCO
$2.94B
$546K ﹤0.01%
18,300
AMRI
2560
DELISTED
Albany Molecular Research Inc
AMRI
$545K ﹤0.01%
54,000
-42,000
-44% -$508K
PRTA icon
2561
Prothena Corp
PRTA
$468M
$544K ﹤0.01%
20,500
+3,600
+21% +$90.3K
BKYF
2562
DELISTED
BK KY FINL CORP
BKYF
$543K ﹤0.01%
14,700
TBNK
2563
DELISTED
Territorial Bancorp Inc.
TBNK
$541K ﹤0.01%
23,313
+720
+3% +$16.5K
REXR icon
2564
Rexford Industrial Realty
REXR
$8.13B
$540K ﹤0.01%
40,892
+7,436
+22% +$101K
RMAX icon
2565
RE/MAX Holdings
RMAX
$243M
$539K ﹤0.01%
+16,800
New +$496K
GST
2566
DELISTED
Gastar Exploration Inc.
GST
$539K ﹤0.01%
77,800
PTLA
2567
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$537K ﹤0.01%
20,839
+648
+3% +$15.7K
VHI icon
2568
Valhi
VHI
$474M
$534K ﹤0.01%
2,531
+174
+7% +$35.2K
PSIX
2569
Power Solutions International
PSIX
$992M
$534K ﹤0.01%
7,109
+360
+5% +$23.6K
POWR
2570
DELISTED
POWERSECURE INTL INC COM STK (DE)
POWR
$534K ﹤0.01%
31,100
+4,100
+15% +$70.4K
XCRA
2571
DELISTED
Xcerra Corporation
XCRA
$530K ﹤0.01%
66,300
SIGM
2572
DELISTED
Sigma Designs Inc
SIGM
$530K ﹤0.01%
112,100
DGII icon
2573
Digi International
DGII
$3.14B
$522K ﹤0.01%
43,000
EXAC
2574
DELISTED
Exactech Inc
EXAC
$522K ﹤0.01%
21,948
+4,248
+24% +$96.9K
FLEX icon
2575
Flex
FLEX
$44.2B
$519K ﹤0.01%
88,618
+4,371
+5% +$26.5K

Similar funds

Charles Schwab's Q4 2013 Portfolio in Review

As of Q4 2013, Charles Schwab held 3,132 positions worth $52.5B, up 7% from $49.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q4 2013: portfolio turnover was 4.1%. Charles Schwab opened 75 new positions and exited 54, leaving the 3,132-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.

  • Charles Schwab's largest Q4 2013 buy was Allergan plc: 398,955 shares worth $67M.
  • Charles Schwab added most to Meta Platforms (Facebook) in Q4 2013, an estimated $94.5M increase.
  • Charles Schwab's biggest Q4 2013 reduction was Apple, cutting an estimated $69.9M.
  • Charles Schwab fully exited DELL INC in Q4 2013, selling an estimated $45.2M.
  • Charles Schwab's ten largest holdings make up 14% of its $52.5B portfolio in Q4 2013.
  • Charles Schwab opened 75 new positions and closed 54 in Q4 2013.
  • Charles Schwab's portfolio value rose 7% quarter-over-quarter to $52.5B.

Based on Charles Schwab's 13F filing for Q4 2013, filed 14 Feb 2014.